Dow Up0.11% Nasdaq Up0.50%

Raptor Pharmaceuticals Corp. (RPTP)

-NasdaqGM
11.02 Up 0.27(2.51%) Aug 29, 4:00PM EDT
|After Hours : 11.02 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Aug 31, 2012
Total Revenue 16,872   -   -  
Cost of Revenue1,653   -   -  
Gross Profit 15,219   -   -  
Operating Expenses
Research Development29,177  8,963  21,443  
Selling General and Administrative37,948  8,971  14,723  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (51,906) (17,934) (36,166)
Income from Continuing Operations
Total Other Income/Expenses Net(10,679)(1,275)(2,475)
Earnings Before Interest And Taxes(62,585)(19,209)(38,641)
Interest Expense6,832  83  3  
Income Before Tax(69,417)(19,292)(38,644)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(69,417)(19,292)(38,644)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (69,417) (19,292) (38,644)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (69,417) (19,292) (38,644)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.